• Potency & Cell-Based Assay Center

Empowering Drug Development

Avance Biosciences is a leading Contract Research Organization (CRO) and Contract Testing Organization (CTO) providing CGMP and GLP-compliant analytical and bioanalytical services to support drug development.

CONTACT US
EXPLORE SERVICES

Empowering Drug Development


Avance Biosciences is a leading CRO and CTO providing CGMP and GLP-compliant assay development, assay validation, and sample testing services to support drug development and manufacturing activities for our clients world-wide.

Comprehensive Testing Solutions
Across Therapeutic Modalities

We provide comprehensive analytical solutions for various drug and biologics modalities, including gene therapies, cell therapies, vaccines, mAbs, ADCs, proteins, and small molecule drugs. These integrated services confirm product sterility, evaluate cellular responses, and quantify therapeutic antibodies and biomarkers, ensuring the safety, efficacy, and quality of pharmaceuticals for regulatory approval and patient well-being.

Comprehensive Testing Solutions Across Therapeutic Modalities

We provide comprehensive analytical solutions for various drug and biologics modalities, including gene therapies, cell therapies, vaccines, mAbs, ADCs, proteins, and small molecule drugs. These integrated services confirm product sterility, evaluate cellular responses, and quantify therapeutic antibodies and biomarkers, ensuring the safety, efficacy, and quality of pharmaceuticals for regulatory approval and patient well-being.

Analytical and Bioanalytical Services
Across Developmental Stages

We provide integrated analytical and bioanalytical testing to support drug and biologics development and manufacturing. Our multidisciplinary capabilities include genomics, cell biology, microbiology, immunoassays, analytical chemistry, and compendial assays, supporting programs from early development through commercialization.

Analytical and Bioanalytical Services Across Developmental Stages

We provide integrated analytical and bioanalytical testing to support drug and biologics development and manufacturing. Our multidisciplinary capabilities include genomics, cell biology, microbiology, immunoassays, analytical chemistry, and compendial assays, supporting programs from early development through commercialization.

State-of-art Technologies

We leverage an array of cutting-edge analytical technologies to drive their analytical and bioanalytical methods. Specializing in seamlessly integrating advanced methodologies across diverse scientific domains with CGMP and GLP regulations, our expertise spans genomics, immunoassays, cell biology, and various other sophisticated techniques.

State-of-art Technologies

We leverage an array of cutting-edge analytical technologies to drive their analytical and bioanalytical methods. Specializing in seamlessly integrating advanced methodologies across diverse scientific domains with CGMP and GLP regulations, our expertise spans genomics, immunoassays, cell biology, and various other sophisticated techniques.

Your Trusted Partner for
Analytical and Bioanalytical Solutions

Our leading scientists have designed and completed hundreds of analytical projects under CGMP/GLP regulations for the FDA, EPA, as well as European and other international regulatory agencies. This team has extensive knowledge and experience working with scientists, QA/QC professionals and project managers from over 300 pharmaceutical and biotechnology companies and organizations around the world.

Your Trusted Partner for Analytical and Bioanalytical Solutions

Our leading scientists have designed and completed hundreds of analytical projects under CGMP/GLP regulations for the FDA, EPA, as well as European and other international regulatory agencies. This team has extensive knowledge and experience working with scientists, QA/QC professionals and project managers from over 300 pharmaceutical and biotechnology companies and organizations around the world.

Cutting Edge Science

Avance Biosciences’ CGMP/GLP compliant analytical and bioanalytical methods make use of the advanced technologies including real-time PCR, ddPCR, Sanger sequencing, next-gen sequencing, ELISA, MSD, Flow Cytometry, and more.

Dedication To Quality

The Avance Biosciences team is committed to strict adherence to CGMP and GLP regulations enacted by the US, European, and other international regulatory agencies.

Extensive Experience

Our team has extensive knowledge and experience working with scientists, QA/QC professionals, and project managers from over 300 pharmaceutical and biotechnology companies and organizations throughout the world.

Open Communication

Transparency and integrity are two of our core values. Our well-trained, friendly, and professional study directors and project managers strive to complete your projects on-time with open communication channels and to your specifications.

Cutting Edge Science

Avance Biosciences’ CGMP/GLP compliant analytical and bioanalytical methods make use of the advanced technologies including real-time PCR, ddPCR, Sanger sequencing, next-gen sequencing, ELISA, MSD, Flow Cytometry, and more.

Dedication To Quality

The Avance Biosciences team is committed to strict adherence to CGMP and GLP regulations enacted by the US, European, and other international regulatory agencies.

Extensive Experience

Our team has extensive knowledge and experience working with scientists, QA/QC professionals, and project managers from over 300 pharmaceutical and biotechnology companies and organizations throughout the world.

Open Communication

Transparency and integrity are two of our core values. Our well-trained, friendly, and professional study directors and project managers strive to complete your projects on-time with open communication channels and to your specifications.

Our Quality System

Our established quality system is based on the requirements of Good Laboratory Practices, current Good Manufacturing Practices, and Quality System Regulation as promulgated by the U.S. Food and Drug Administration 21 CFR Part 58, 21 CFR Parts 210, 211, and 820 respectively, and by European and other international regulatory agencies.

Our Quality System

Our established quality system is based on the requirements of Good Laboratory Practices, current Good Manufacturing Practices, and Quality System Regulation as promulgated by the U.S. Food and Drug Administration 21 CFR Part 58, 21 CFR Parts 210, 211, and 820 respectively, and by European and other international regulatory agencies.

News & Events

  • Festival of Biologics USA 2026
Avance Biosciences to Exhibit at Festival of Biologics USA 2026

January 20th, 2026|

Avance Biosciences will be exhibiting at Festival of Biologics USA 2026 in San Diego. Visit us at Booth #322 to learn how our CGMP-, GLP-, and CLIA-compliant bioanalytical services support biologics development, from assay development and validation to potency, immunogenicity, and advanced analytical testing[...]

When you partner with Avance Biosciences™, you gain a CRO partner that is creative, collaborative and dedicated to sound science with a focus on the regulatory requirements our partners require. Contact our technical staff to discuss how we can support you in your project!

CRO Partner

News & Events